---
category: news
title: "Opin season arrives for patients as AI drives Opyl boom in Q2 receipts"
excerpt: "Aussie startup Opyl had another strong December quarter â€“ customer registrations have almost doubled as demand for its AI-powered clinical trial recruitment platform, Opin, grows. Medical technology company Opyl (ASX:OPL) has delivered positive Q2 FY22 results with a closing cash balance of $1."
publishedDateTime: 2022-01-30T23:54:00Z
originalUrl: "https://stockhead.com.au/health/opin-season-arrives-for-patients-as-ai-drives-opyl-boom-in-q2-receipts/"
webUrl: "https://stockhead.com.au/health/opin-season-arrives-for-patients-as-ai-drives-opyl-boom-in-q2-receipts/"
ampWebUrl: "https://stockhead.com.au/health/opin-season-arrives-for-patients-as-ai-drives-opyl-boom-in-q2-receipts/?amp"
cdnAmpWebUrl: "https://stockhead-com-au.cdn.ampproject.org/c/s/stockhead.com.au/health/opin-season-arrives-for-patients-as-ai-drives-opyl-boom-in-q2-receipts/?amp"
type: article
quality: 57
heat: 57
published: false

provider:
  name: stockhead
  domain: stockhead.com.au

topics:
  - AI

images:
  - url: "https://stockhead.com.au/wp-content/uploads/2022/01/OPL-scaled.jpg"
    width: 2560
    height: 1725
    isCached: true

secured: "fgk7ctD/Y1s2dZSW3hIiZemFFRTM2NLVVtptE6uXGBq6y+gb1s3gT1GG3f9ku0BZZePxt/0L+33GJW5gVWI4rb7Ch4zNgaW2HwJhO7fZLXxcZvSFC6LgtjU/I+CCy6laUNs5+MdAwAfLlKwkMQFBhL4yyk8oL6wAX3/LDgayw+2mPKY30YdoKLBo7nwO41tAYuQ4kIU8CJIdhRegms0CKmU1UeP0V4w8csdSRo9KTPUyQvqLdTS0Oojk0EsJ6O3winVqVwFnrU3HEr0JZyUp4q29IrSgPcwoqlzgED359F4+aujUi9+OMxNdc4EsZqRPEfeblSRqKPlkY5l2g0ghDGW3Ymwqy8PA5aZszs1wxdQ=;qdMGiPGckuJ3i7Y6fGw/Gg=="
---

